Skip to content
Menu
About Us
Company Overview
Management
Board of Directors
Our Science
Overview of Assets
Science
Pipeline
Clinical Trials
Expanded Access Policy
Newsroom
Press Releases
Events & Presentations
Investor Relations
Corporate Governance
Financial Information
Annual Reports & Proxy Statements
Investor Contact Info
Contact
Close Menu
Press Releases
October 6, 2016
SBP Receives DSMB Approval to Start 4th Patient Cohort in SBP-101 Dose Escalation Phase 1 Study
View/download press release »
Sign up to receive press releases via email
Leave this field empty if you're human:
